Patents by Inventor Yanhong Shi

Yanhong Shi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCERS OF INDUCED PLURIPOTENT STEM CELL REPROGRAMMING
    Publication number: 20150191701
    Abstract: Described herein, inter alia, are methods and compositions useful for induced pluripotent stem cell reprogramming.
    Type: Application
    Filed: January 7, 2015
    Publication date: July 9, 2015
    Inventors: Yanhong Shi, Man Lun Yip, Wendong Li
  • Enhancers of induced pluripotent stem cell reprogramming
    Patent number: 8962322
    Abstract: Described herein, inter alia, are methods and compositions useful for induced pluripotent stem cell reprogramming.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: February 24, 2015
    Assignee: City of Hope
    Inventors: Yanhong Shi, Man Lun Yip, Wendong Li
  • ENHANCERS OF INDUCED PLURIPOTENT STEM CELL REPROGRAMMING
    Publication number: 20140154805
    Abstract: Described herein, inter alia, are methods and compositions useful for induced pluripotent stem cell reprogramming.
    Type: Application
    Filed: October 15, 2013
    Publication date: June 5, 2014
    Applicant: City of Hope
    Inventors: Yanhong Shi, Man Lun Yip, Wendong Li
  • DIFFERENTIALLY EXPRESSED MICRORNA MOLECULES FOR THE TREATMENT AND DIAGNOSIS OF CANCER
    Publication number: 20140088170
    Abstract: A significant challenge in cancer research field is to define molecular features that distinguish cancer stem cells from normal stem cells. In this study, microRNA (miRNA) expression profiles in human glioblastoma stem cells were compared to that of normal neural stem cells using combined microarray and deep sequencing analyses. These studies led to the identification of several miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. Characterizing the role of these miRNAs in glioblastoma stem cells is important for the development of miRNA-based therapies that specifically target tumor stem cells, but spare normal stem cells.
    Type: Application
    Filed: August 29, 2013
    Publication date: March 27, 2014
    Inventors: Yanhong Shi, Ming-Fei Lang, Chunnian Zhao